Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: Phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group

Howard Hochster, Elizabeth R. Plimack, Carolyn D. Runowicz, James Speyer, Robert C. Wallach, Joan Sorich, John Mandeli, Scott Wadler, John Wright, Franco M. Muggia

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: Phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group'. Together they form a unique fingerprint.

Medicine and Dentistry